Balchem Corp. (BCPC)
-NasdaqGS 46.12 
0.68(1.45%) 4:00PM EDT|After Hours
:
46.12 0.00 (0.00%) 4:32PM EDT
| Prev Close: | 46.80 |
|---|
| Open: | 46.55 |
|---|
| Bid: | 1.00 x 300 |
|---|
| Ask: | 50.00 x 100 |
|---|
| 1y Target Est: | 48.25 |
|---|
| Beta: | 0.69 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 45.75 - 46.96 |
|---|
| 52wk Range: | 30.77 - 48.76 |
|---|
| Volume: | 105,755 |
|---|
| Avg Vol (3m): | 72,452 |
|---|
| Market Cap: | 1.37B |
|---|
| P/E (ttm): | 33.66 |
|---|
| EPS (ttm): | 1.37 |
|---|
| Div & Yield: | 0.22 (0.50%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Here's Why Balchem's Latest Report Might Worry Youat Motley Fool(Wed, Jun 12)
- BALCHEM CORP Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Wed, Jun 5)
- McKesson CEO Sells 75K Shares and 4 Insider Sales to Noteat Wall St. Cheat Sheet(Tue, May 14)
- BALCHEM CORP FinancialsEDGAR Online Financials(Fri, May 10)
- Balchem's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Fri, May 3)
- Balchem Corporation Announces First Quarter 2013 ResultsGlobeNewswire(Fri, May 3)
- Q1 2013 Balchem Corp Earnings Release - 09:30 am ETCCBN(Fri, May 3)
- BALCHEM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Fri, May 3)
- Stepan Co: Steppin' Up Dividend Growthat Seeking Alpha(Wed, May 1)
- Balchem Corporation Announces Quarterly Conference Call for First Quarter 2013 Financial Results on May 3, 2013GlobeNewswire(Thu, Apr 18)
- Mon, Bayer in Cross-Licensing DealZacks(Thu, Apr 18)
- Mon, Dow in Cross-License DealZacks(Mon, Apr 15)
- Ecolab Completes Champions BuyoutZacks(Fri, Apr 12)
- Sigma Joins Public Health EnglandZacks(Wed, Apr 10)
- ECL Progresses on Deal with ChampionZacks(Wed, Apr 10)
Key Statistics
| Forward P/E (1 yr): | 24.15 |
|---|
| P/S (ttm): | 4.36 |
|---|
| Ex-Dividend Date: | 12-Dec-12 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 1.55 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.39 |
|---|
| Mean Recommendation*: | 1.8 |
|---|
| PEG Ratio (5 yr expected): | 2.52 |
|---|
Business Summary
Balchem Corporation develops, manufactures, and sells specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, and medical sterilization industries in the United States and internationally.
View More